/
Pharmaceutical preparations company · NV · FY ends Aug · Revenue $368K · -2571.89% margin · -$9M FCF
The business is unprofitable at the operating level (-1683.01% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 52.0%, still solid. Margins contracted 443.9pp, which offsets some of the top-line progress.
ROIC dropped from -78.91% to -164.52%, capital efficiency is deteriorating. Negative free cash flow of -$10M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$368K
▲ +52.0% YoY
Net Income (TTM)
-$10M
▼ -105.4% YoY
Op. Margin
-2571.89%
▼ -443.9pp YoY
ROIC
-146.04%
▼ -85.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$9M
▼ -109.4% YoY
Op. Cash Flow (TTM)
-$9M
▼ -110.7% YoY
Net Debt
-$5M
Net Cash Position
Cash & Equiv.
$5M
5Y CAGR: +17.5%
Continue Research